pH-responsive glucosamine anchored polydopamine coated mesoporous silica nanoparticles for delivery of Anderson-type polyoxomolybdate in breast cancer

References

• Barbosa, A.M., and Martel, F., 2020. Targeting glucose transporters for breast cancer therapy: the effect of natural and synthetic compounds. Cancers, 12 (1), 154.
   PubMed Web of Science ®Google Scholar
• Batul, R., et al., 2017. Recent progress in the biomedical applications of polydopamine nanostructures. Biomaterials science, 5 (7), 1204–1229.
   PubMed Web of Science ®Google Scholar
• Beagan, A., et al., 2020. Glucosamine modified the surface of pH-responsive poly (2-(diethylamino) ethyl Methacrylate) brushes grafted on hollow mesoporous silica nanoparticles as smart nanocarrier. Polymers, 12 (11), 2749.
   PubMed Web of Science ®Google Scholar
• Bi, D., et al., 2018. Surface modification of doxorubicin-loaded nanoparticles based on polydopamine with pH-sensitive property for tumor targeting therapy. Drug delivery, 25 (1), 564–575.
   PubMed Web of Science ®Google Scholar
• Bijelic, A., Aureliano, M., and Rompel, A., 2019. Polyoxometalates as potential next‐generation metallodrugs in the combat against cancer. Angewandte chemie (international ed. in english), 58 (10), 2980–2999.
   PubMed Web of Science ®Google Scholar
• Black, K.C., et al., 2013. Polydopamine-enabled surface functionalization of gold nanorods for cancer cell-targeted imaging and photothermal therapy. Nanomedicine (london, England), 8 (1), 17–28.
   PubMed Web of Science ®Google Scholar
• Blazevic, A., et al., 2015. Tris‐functionalized hybrid Anderson polyoxometalates: synthesis, characterization, hydrolytic stability and inversion of protein surface charge. Chemistry (weinheim an der bergstrasse, Germany), 21 (12), 4762–4771.
   PubMed Web of Science ®Google Scholar
• Blazevic, A., and Rompel, A., 2016. The Anderson–Evans polyoxometalate: From inorganic building blocks via hybrid organic–inorganic structures to tomorrows “Bio-POM. Coordination chemistry reviews, 307, 42–64.
   Web of Science ®Google Scholar
• Cao, H., et al., 2017. Synthesis, cytotoxicity and antitumour mechanism investigations of polyoxometalate doped silica nanospheres on breast cancer MCF-7 cells. PloS one, 12 (7), e0181018.
   PubMed Web of Science ®Google Scholar
• Chang, D., et al., 2016. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy. Journal of colloid and interface science, 463, 279–287.
   PubMed Web of Science ®Google Scholar
• Cheng, W., et al., 2017. pH-sensitive delivery vehicle based on folic acid-conjugated polydopamine-modified mesoporous silica nanoparticles for targeted cancer therapy. ACS applied materials & interfaces, 9 (22), 18462–18473.
   PubMed Web of Science ®Google Scholar
• Duo, Y., et al., 2017. DOX-loaded pH-sensitive mesoporous silica nanoparticles coated with PDA and PEG induce pro-death autophagy in breast cancer. RSC advances, 7 (63), 39641–39650.
   Web of Science ®Google Scholar
• Fallahian, F., et al., 2011. Cyclic GMP induced apoptosis via protein kinase G in oestrogen receptor‐positive and‐negative breast cancer cell lines. The FEBS journal, 278 (18), 3360–3369.
   PubMed Web of Science ®Google Scholar
• Geisberger, G., et al., 2013. Synthesis, characterization and bioimaging of fluorescent labeled polyoxometalates. Dalton transactions (cambridge, England : 2003), 42 (27), 9914–9920.
   PubMed Web of Science ®Google Scholar
• Geisberger, G., et al., 2011. Targeted delivery of polyoxometalate nanocomposites. Small (weinheim an der bergstrasse, Germany), 7 (19), 2808–2814.
   PubMed Web of Science ®Google Scholar
• Gittings, M., and Saville, D., 1998. The determination of hydrodynamic size and zeta potential from electrophoretic mobility and light scattering measurements. Colloids and surfaces A: Physicochemical and engineering aspects, 141 (1), 111–117.
   Web of Science ®Google Scholar
• Grever, M. R., Schepartz, S. A., and Chabner, B. A., 1992. The national cancer institute: cancer drug discovery and development programed. Seminars in oncology, 19 (6), 622–638.
   Google Scholar
• Gullotti, E., Park, J., and Yeo, Y., 2013. Polydopamine-based surface modification for the development of peritumorally activatable nanoparticles. Pharmaceutical research, 30 (8), 1956–1967.
   PubMed Web of Science ®Google Scholar
• Gündüz, T., Gündüz, N., and Şakiyan, İ., 1994. A new method for synthesis of manganese (III) acetate dihydrate. Synthesis and reactivity in inorganic and Metal-Organic chemistry, 24 (4), 519–524.
   Web of Science ®Google Scholar
• Hassett, M.J., et al., 2006. Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. JNCI: Journal of the national cancer institute, 98 (16), 1108–1117.
   PubMedGoogle Scholar
• He, Y., et al., 2017. Mesoporous silica nanoparticles as potential carriers for enhanced drug solubility of paclitaxel. Materials science & engineering. C, materials for biological applications, 78, 12–17.
   PubMed Web of Science ®Google Scholar
• Hickey, S.M., et al., 2021. Fluorescence microscopy—an outline of hardware, biological handling, and fluorophore considerations. Cells, 11 (1), 35.
   PubMed Web of Science ®Google Scholar
• Honary, S., and Zahir, F., 2013. Effect of zeta potential on the properties of nano-drug delivery systems-a review (Part 2). Tropical journal of pharmaceutical research, 12 (2), 265–273.
   Google Scholar
• Hosseini, M.S., et al., 2020. Anti-cancer activity of biotin-polyoxomolybdate bioconjugate. Eurasian journal of medicine and oncology, 4 (1), 42–48.
   Google Scholar
• Inumaru, K., et al., 2007. Water‐tolerant, highly active solid acid catalysts composed of the keggin‐type polyoxometalate H3PW12O40 immobilized in hydrophobic nanospaces of organomodified mesoporous silica. Angewandte chemie (international ed. in english), 46 (40), 7625–7628.
   PubMed Web of Science ®Google Scholar
• Ji, F., et al., 2018. Engineering polyzwitterion and polydopamine decorated doxorubicin-loaded mesoporous silica nanoparticles as a pH-sensitive drug delivery. Polymers, 10 (3), 326.
   PubMed Web of Science ®Google Scholar
• Kalyane, D., et al., 2019. Employment of enhanced permeability and retention effect (EPR): nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer. Materials science & engineering. C, materials for biological applications, 98, 1252–1276.
   PubMed Web of Science ®Google Scholar
• Kirin, S.I., et al., 2008. Cellular uptake quantification of metalated peptide and peptide nucleic acid bioconjugates by atomic absorption spectroscopy. Angewandte chemie (international ed. in english), 47 (5), 955–959.
   PubMed Web of Science ®Google Scholar
• Kruszewska, J., et al., 2019. An improved protocol for ICP-MS-based assessment of the cellular uptake of metal-based nanoparticles. Journal of pharmaceutical and biomedical analysis, 174, 300–304.
   PubMed Web of Science ®Google Scholar
• Laudański, P., et al., 2003. Expression of GLUT1 gene in breast cancer cell lines MCF-7 and MDA-MB-231. Ginekologia polska, 74 (9), 782–785.
   PubMedGoogle Scholar
• Li, X., et al., 2018. pH and ultrasound dual-responsive polydopamine-coated mesoporous silica nanoparticles for controlled drug delivery. Langmuir : the ACS journal of surfaces and colloids, 34 (34), 9974–9981.
   PubMed Web of Science ®Google Scholar
• Liu, C.-Y., and Huang, C.-J., 2016. Functionalization of polydopamine via the aza-michael reaction for antimicrobial interfaces. Langmuir : the ACS journal of surfaces and colloids, 32 (19), 5019–5028.
   PubMed Web of Science ®Google Scholar
• Liu, J., et al., 2014. pH-sensitive nano-systems for drug delivery in cancer therapy. Biotechnology advances, 32 (4), 693–710.
   PubMed Web of Science ®Google Scholar
• Liu, X., et al., 2019. Construction of bio/nanointerfaces: stable gold nanoparticle bioconjugates in complex systems. ACS applied materials & interfaces, 11 (43), 40817–40825.
   PubMed Web of Science ®Google Scholar
• Liu, Y., et al., 2005. In vitro inhibitory effect of polyoxometalates on human tumor cells. Transition metal chemistry, 30 (1), 113–117.
   Web of Science ®Google Scholar
• Lyle, S.J., et al., 2018. Facilitating laboratory research experience using reticular chemistry. Journal of chemical education, 95 (9), 1512–1519.
   Web of Science ®Google Scholar
• Mahmoud, N.N., et al., 2021. Colloidal stability and cytotoxicity of polydopamine-conjugated gold nanorods against prostate cancer cell lines. Molecules, 26 (5), 1299.
   PubMed Web of Science ®Google Scholar
• Marcoux, P.R., et al., 2003. Developing remote metal binding sites in heteropolymolybdates. European journal of inorganic chemistry, 2003 (13), 2406–2412.
   Web of Science ®Google Scholar
• Menon, D., et al., 2011. A novel chitosan/polyoxometalate nano-complex for anti-cancer applications. Carbohydrate polymers, 84 (3), 887–893.
   Web of Science ®Google Scholar
• Mirante, F., et al., 2017. Sustainable desulfurization processes catalyzed by Titanium-Polyoxometalate@ TM-SBA-15. Topics in catalysis, 60 (15-16), 1140–1150.
   Web of Science ®Google Scholar
• Mitsui, S., et al., 2006. Antitumor activity of polyoxomolybdate,[NH3Pri] 6 [Mo7O24] ·  3H2O, against, human gastric cancer model. Biomedicine & pharmacotherapy = biomedecine & pharmacotherapie, 60 (7), 353–358.
   PubMed Web of Science ®Google Scholar
• Moore, T.L., et al., 2015. Nanoparticle colloidal stability in cell culture media and impact on cellular interactions. Chemical society reviews, 44 (17), 6287–6305.
   PubMed Web of Science ®Google Scholar
• Moreno-VillaéCija, M-a., et al., 2018. Polydopamine-like coatings as payload gatekeepers for mesoporous silica nanoparticles. ACS applied materials & interfaces, 10 (9), 7661–7669.
   PubMed Web of Science ®Google Scholar
• Mukherjee, H.N., 1965. Treatment of cancer of the intestinal tract with a complex compound of phosphotungstic phosphomolybdic acids and caffeine. Journal of the indian medical association, 44, 477–479.
   PubMedGoogle Scholar
• Ott, I., et al., 2005. Antitumor-active cobalt − alkyne complexes derived from acetylsalicylic acid: studies on the mode of drug action. Journal of medicinal chemistry, 48 (2), 622–629.
   PubMed Web of Science ®Google Scholar
• Pada, A.-K., et al., 2019. Comparison of polydopamine-coated mesoporous silica nanorods and spheres for the delivery of hydrophilic and hydrophobic anticancer drugs. International journal of molecular sciences, 20 (14), 3408.
   PubMed Web of Science ®Google Scholar
• Pfeffer, C.M., and Singh, A.T., 2018. Apoptosis: a target for anticancer therapy. International journal of molecular sciences, 19 (2), 448.
   PubMed Web of Science ®Google Scholar
• Prokopowicz, M., et al., 2018. Surface-activated fibre-like SBA-15 as drug carriers for bone diseases. AAPS PharmSciTech, 20 (1), 17.
   PubMed Web of Science ®Google Scholar
• Rahmatolahzadeh, R., et al., 2018. Aspartic acid functionalized PEGylated MSN@ GO hybrid as an effective and sustainable nano-system for in-vitro drug delivery. Advances in medical sciences, 63 (2), 257–264.
   PubMed Web of Science ®Google Scholar
• Ramezani-Aliakbari, M., et al., 2021a. Eudesmic acid-polyoxomolybdate organo-conjugate as novel anticancer agent. Journal of molecular structure, 1240, 130612.
   Web of Science ®Google Scholar
• Ramezani-Aliakbari, M., et al., 2021b. Biotin-targeted nanomicellar formulation of an Anderson-type polyoxomolybdate: synthesis and in vitro cytotoxicity evaluations. Langmuir : the ACS journal of surfaces and colloids, 37 (21), 6475–6489.
   PubMed Web of Science ®Google Scholar
• Ribeiro, S.O., et al., 2019. Oxidative desulfurization strategies using Keggin-type polyoxometalate catalysts: biphasic versus solvent-free systems. Catalysis today, 333, 226–236.
   Web of Science ®Google Scholar
• Rogers, S., et al., 2002. Identification of a novel glucose transporter-like protein—GLUT-12. American journal of physiology. Endocrinology and metabolism, 282 (3), E733–E738.
   PubMed Web of Science ®Google Scholar
• Ryu, J.H., Messersmith, P.B., and Lee, H., 2018. Polydopamine surface chemistry: a decade of discovery. ACS applied materials & interfaces, 10 (9), 7523–7540.
   PubMed Web of Science ®Google Scholar
• Scheffer, F.R., et al., 2020. Tailoring pseudo-zwitterionic bifunctionalized silica nanoparticles: from colloidal stability to biological interactions. Langmuir : the ACS journal of surfaces and colloids, 36 (36), 10756–10763.
   PubMed Web of Science ®Google Scholar
• Schneid, A.D.C., et al., 2020. Colloidal stability and redispersibility of mesoporous silica nanoparticles in biological media. Langmuir: the ACS journal of surfaces and colloids, 36 (39), 11442–11449.
   PubMed Web of Science ®Google Scholar
• Selestin Raja, I., Thangam, R., and Fathima, N.N., 2018. Polymeric micelle of a gelatin-oleylamine conjugate: a prominent drug delivery carrier for treating triple negative breast cancer cells. ACS applied bio materials, 1 (5), 1725–1734.
   PubMedGoogle Scholar
• Shah, H.S., et al., 2014. Cytotoxicity and enzyme inhibition studies of polyoxometalates and their chitosan nanoassemblies. Toxicology reports, 1, 341–352.
   PubMedGoogle Scholar
• Shakeela, K., et al., 2018. Polyoxometalate entrapped caprolactam gels and their cytotoxicity study. Journal of chemical sciences, 130 (8), 1–6.
   Web of Science ®Google Scholar
• Shan, X.H., et al., 2012. Targeting Glut1-overexpressing MDA-MB-231 cells with 2-deoxy-d-g1ucose modified SPIOs. European journal of radiology, 81 (1), 95–99.
   PubMed Web of Science ®Google Scholar
• Singh, R., and Lillard, J.W., Jr, 2009. Nanoparticle-based targeted drug delivery. Experimental and molecular pathology, 86 (3), 215–223.
   PubMed Web of Science ®Google Scholar
• Sun, G., et al., 2009. pH-responsive controlled release of antitumour-active polyoxometalate from mesoporous silica materials. Dalton transactions, 23, 4481–4487.
   Web of Science ®Google Scholar
• Szablewski, L., 2013. Expression of glucose transporters in cancers. Biochimica et biophysica acta, 1835 (2), 164–169.
   PubMed Web of Science ®Google Scholar
• Tran, A.-V., et al., 2018. Targeted and controlled drug delivery by multifunctional mesoporous silica nanoparticles with internal fluorescent conjugates and external polydopamine and graphene oxide layers. Acta biomaterialia, 74, 397–413.
   PubMed Web of Science ®Google Scholar
• Uthappa, U., et al., 2019. Facile green synthetic approach of bio inspired polydopamine coated diatoms as a drug vehicle for controlled drug release and active catalyst for dye degradation. Microporous and mesoporous materials, 288, 109572.
   Web of Science ®Google Scholar
• Van Speybroeck, M., et al., 2009. Ordered mesoporous silica material SBA-15: a broad-spectrum formulation platform for poorly soluble drugs. Journal of pharmaceutical sciences, 98 (8), 2648–2658.
   PubMed Web of Science ®Google Scholar
• Visser, L.L., et al., 2019. Predictors of an invasive breast cancer recurrence after DCIS: a systematic review and meta-analyses. Cancer epidemiology, biomarkers & prevention: a publication of the American association for cancer research, cosponsored by the American society of preventive oncology, 28 (5), 835–845.
   PubMed Web of Science ®Google Scholar
• Wan, M.M., et al., 2016. In situ loading of drugs into mesoporous silica SBA‐15. Chemistry (weinheim an der bergstrasse, Germany), 22 (18), 6294–6301.
   PubMed Web of Science ®Google Scholar
• Wei, Y., et al., 2017. Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy. Drug delivery, 24 (1), 681–691.
   PubMed Web of Science ®Google Scholar
• Yamase, T., 2005. Anti-tumor,-viral, and-bacterial activities of polyoxometalates for realizing an inorganic drug. Journal of materials chemistry, 15 (45), 4773–4782.
   Web of Science ®Google Scholar
• Yang, C.-M., et al., 2003. Highly dispersed metal nanoparticles in functionalized SBA-15. Chemistry of materials, 15 (1), 275–280.
   Web of Science ®Google Scholar
• Yang, H.-K., et al., 2013. Polyoxometalate–biomolecule conjugates: a new approach to create hybrid drugs for cancer therapeutics. Bioorganic & medicinal chemistry letters, 23 (5), 1462–1466.
   PubMed Web of Science ®Google Scholar
• Yin, Y., et al., 2017. Modification of as synthesized SBA-15 with Pt nanoparticles: nanoconfinement effects give a boost for hydrogen storage at room temperature. Scientific reports, 7 (1), 1–10.
   PubMed Web of Science ®Google Scholar
• Zaman, M.S., et al., 2016. Curcumin nanoformulation for cervical cancer treatment. Scientific reports, 6, 20051–20014.
   PubMed Web of Science ®Google Scholar
• Zamani, M., et al., 2019. Co1−XZnxFe2O4 based nanocarriers for dual-targeted anticancer drug delivery: synthesis, characterization and in vivo and in vitro biocompatibility study. Journal of molecular liquids, 274, 60–67.
   Web of Science ®Google Scholar
• Zhang, R., and Yang, C., 2008. A novel polyoxometalate-functionalized mesoporous hybrid silica: synthesis and characterization. Journal of materials chemistry, 18 (23), 2691–2703.
   Web of Science ®Google Scholar
• Zhang, Y., et al., 2017. Tumor-targeting micelles based on linear–dendritic PEG–PTX8 conjugate for triple negative breast cancer therapy. Molecular pharmaceutics, 14 (10), 3409–3421.
   PubMed Web of Science ®Google Scholar
• Zheng, X., et al., 2015. Polydopamine coatings in confined nanopore space: toward improved retention and release of hydrophilic cargo. The journal of physical chemistry, 119 (43), 24512–24521.
   Web of Science ®Google Scholar